LivaNova Stock

LivaNova Liabilities 2024

LivaNova Liabilities

1.15 B USD

Ticker

LIVN

ISIN

GB00BYMT0J19

WKN

A14156

In 2024, LivaNova's total liabilities amounted to 1.15 B USD, a 5.96% difference from the 1.09 B USD total liabilities in the previous year.

LivaNova Aktienanalyse

What does LivaNova do?

LivaNova PLC is a global medical technology company specializing in the development and manufacturing of devices and therapies for cardiovascular diseases, epilepsy, and brain disorders. The company was founded in 2015 through the merger of Sorin Group and Cyberonics, and in 2019, a legal dispute resulted in the agreement to make compensation payments. The company is divided into three main divisions: cardiac surgery, neuromodulation, and cardiac rhythm management. Each division offers different products for their target markets. The cardiac surgery division provides devices for surgical treatment of cardiovascular diseases, such as heart valve repair and replacement systems, cardioplegia systems for heart cooling during surgery, and mechanical heart support systems for patients with severe heart failure. Neuromodulation specializes in the treatment of epilepsy, brain injuries, and psychiatric disorders. The division offers both implantable devices directly implanted in the brain and external devices that use magnetic fields to influence brain activity. The cardiac rhythm management division focuses on the treatment of heart rhythm disorders and offers pacemakers, implantable cardioverter-defibrillators (ICDs), catheters, and ablation systems to correct electrical changes in the heart. LivaNova is headquartered in London and has manufacturing facilities in North America, Europe, and Asia. The company works closely with clinical partners worldwide to understand the medical needs of patients and develop new products and therapies aimed at improving patients' lives. Overall, LivaNova's business model is centered around commitment to innovation, production, and global presence. The company aims to improve the quality of healthcare and provide better therapies and devices to patients worldwide. The focus of product development is often a balance of effectiveness, safety, and patient comfort. The answer is: LivaNova is a global medical technology company specializing in the development and manufacturing of devices and therapies for cardiovascular diseases, epilepsy, and brain disorders. LivaNova ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing LivaNova's Liabilities

LivaNova's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating LivaNova's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing LivaNova's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

LivaNova's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in LivaNova’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about LivaNova stock

What is the level of liabilities of LivaNova this year?

LivaNova has a debt balance of 1.15 B USD this year.

What were the liabilities of LivaNova compared to the previous year?

The liabilities of LivaNova have increased by 5.96% increased compared to the previous year.

What are the consequences of high debt for investors of LivaNova?

High liabilities can pose a risk for investors of LivaNova, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in LivaNova?

Low liabilities mean that LivaNova has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of LivaNova affect the company?

An increase in liabilities of LivaNova can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of LivaNova affect the company?

A decrease in the liabilities of LivaNova can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of LivaNova?

Some factors that can influence the liabilities of LivaNova include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of LivaNova so important for investors?

The liabilities of LivaNova are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can LivaNova take to modify the liabilities?

To change its liabilities, LivaNova can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does LivaNova pay?

Over the past 12 months, LivaNova paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, LivaNova is expected to pay a dividend of 0 USD.

What is the dividend yield of LivaNova?

The current dividend yield of LivaNova is .

When does LivaNova pay dividends?

LivaNova pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of LivaNova?

LivaNova paid dividends every year for the past 0 years.

What is the dividend of LivaNova?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is LivaNova located?

LivaNova is assigned to the 'Health' sector.

Wann musste ich die Aktien von LivaNova kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of LivaNova from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did LivaNova pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of LivaNova in the year 2023?

In the year 2023, LivaNova distributed 0 USD as dividends.

In which currency does LivaNova pay out the dividend?

The dividends of LivaNova are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The LivaNova stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von LivaNova

Our stock analysis for LivaNova Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LivaNova Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.